CVE-2019-1229

Dynamics On-Premise Elevation of Privilege Vulnerability

Description

An elevation of privilege vulnerability exists in Dynamics On-Premise v9. An attacker who successfully exploited the vulnerability could leverage a customizer privilege within Dynamics to gain control of the Web Role hosting the Dynamics installation. To exploit this vulnerability, an attacker needs to have credentials for a user that has permission to author customized business rules in Dynamics, and persist XAML script in a way that causes it to be interpreted as code. The update addresses the vulnerability by restricting XAML activities to a whitelisted set.

8.8
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 12.82% Top 10%
Vendor Advisory microsoft.com
Affected: Microsoft Microsoft Dynamics 365 (on-premises) version 9.0
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2019-1229?
CVE-2019-1229 has been scored as a high severity vulnerability.
How to fix CVE-2019-1229?
To fix CVE-2019-1229, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2019-1229 being actively exploited in the wild?
It is possible that CVE-2019-1229 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~13% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2019-1229?
CVE-2019-1229 affects Microsoft Microsoft Dynamics 365 (on-premises) version 9.0.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.